Patient Registry Software Market
Global Patient Registry Software Strategic Business Report 2024: Market to Reach $2.4 Billion by 2027 - Disease Registries Segment to Record 12.2% CAGR
20 févr. 2024 06h50 HE | Research and Markets
Dublin, Feb. 20, 2024 (GLOBE NEWSWIRE) -- The "Patient Registry Software: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global Patient Registry...
22157.jpg
Global Patient Registry Software Market Analysis and Outlook to 2028: Dacima Software, FIGmd, Global Vision Technologies, Image Trend, and IQVIA Dominate the Landscape
26 janv. 2024 09h02 HE | Research and Markets
Dublin, Jan. 26, 2024 (GLOBE NEWSWIRE) -- The "Patient Registry Software Market - Global Industry Size, Share, Trends Opportunity, and Forecast 2018-2028" report has been added to ...
Patient Registry Software Market
Global Patient Registry Software Market is set to grow at a CAGR of 11-14% by 2027 - Transforming Healthcare Information System
15 mai 2023 10h00 HE | Medi-Tech Insights
BRUSSELS, BELGIUM, May 15, 2023 (GLOBE NEWSWIRE) -- A patient registry is an organized system to collect uniform data from a group of individuals who share a common disease or treatment. It is a...
lipella logo.png
Announcing Radiation (and Hemorrhagic) Cystitis Patient Registry: for people affected by pelvic radiation during cancer treatment
10 mai 2022 15h27 HE | Lipella Pharmaceuticals, Inc.
Pittsburgh, Pennsylvania, United States , May 10, 2022 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals, Inc. is announcing the Radiation Cystitis Patient Registry, an on-line patient registry program...
22157.jpg
Global Patient Registry Software Market to Double in Size from $1.4 Billion in 2021 to $2.8 Billion by 2026
12 nov. 2021 07h28 HE | Research and Markets
Dublin, Nov. 12, 2021 (GLOBE NEWSWIRE) -- The "Patient Registry Software Market by Type of Registry (Diabetes, Cancer, Rare Disease, Asthma, Kidney), Software (Integrated and Standalone), Delivery...
KINIKSA _2c_final - Copy.jpg
Kiniksa Launches Patient Registry (RESONANCE) for Recurrent Pericarditis
02 mars 2021 08h00 HE | Kiniksa Pharmaceuticals, Ltd.
HAMILTON, Bermuda, March 02, 2021 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) (“Kiniksa”), a biopharmaceutical company with a pipeline of assets designed to modulate...